Compare PRGO & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRGO | STAA |
|---|---|---|
| Founded | 1887 | 1982 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2013 | 1995 |
| Metric | PRGO | STAA |
|---|---|---|
| Price | $9.95 | $29.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $19.33 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 3.2M | 590.8K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 10.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $800,000.00 | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | $1.02 | $8.41 |
| P/E Ratio | ★ N/A | $312.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.23 | $15.59 |
| 52 Week High | $28.44 | $35.87 |
| Indicator | PRGO | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 51.13 |
| Support Level | $9.24 | $28.10 |
| Resistance Level | $11.88 | $31.05 |
| Average True Range (ATR) | 0.59 | 1.13 |
| MACD | -0.10 | -0.03 |
| Stochastic Oscillator | 16.05 | 44.83 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.